| Correlation Between Biofilm-Formation and the Antibiotic Resistant Phenotype in Staphylococcus aureus Isolates: A Laboratory-Based Study in Hungary and a … SA Senobar Tahaei, A Stájer, I Barrak, E Ostorházi, D Szabó, M Gajdács Infection and drug resistance, 1155-1168, 2021 | 87 | 2021 |
| Bladder cancer-related microbiota: Examining differences in urine and tissue samples B Mansour, Á Monyók, N Makra, M Gajdács, I Vadnay, B Ligeti, J Juhász, ... Scientific Reports 10 (1), 11042, 2020 | 78 | 2020 |
| Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the … E Ostorhazi, MC Holub, F Rozgonyi, F Harmos, M Cassone, JD Wade, ... International journal of antimicrobial agents 37 (5), 480-484, 2011 | 75 | 2011 |
| The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models D Szabo, E Ostorhazi, A Binas, F Rozgonyi, B Kocsis, M Cassone, ... International journal of antimicrobial agents 35 (4), 357-361, 2010 | 75 | 2010 |
| Polyvinyl alcohol nanofiber formulation of the designer antimicrobial peptide APO sterilizes Acinetobacter baumannii-infected skin wounds in mice I Sebe, E Ostorhazi, A Fekete, KN Kovacs, R Zelko, I Kovalszky, W Li, ... Amino acids 48, 203-211, 2016 | 58 | 2016 |
| Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterials JC McPherson III, R Runner, TB Buxton, JF Hartmann, D Farcasiu, ... European journal of medicinal chemistry 47, 615-618, 2012 | 57 | 2012 |
| The antibacterial effect of a proline-rich antibacterial peptide A3-APO F Rozgonyi, D Szabo, B Kocsis, E Ostorhazi, G Abbadessa, M Cassone, ... Current medicinal chemistry 16 (30), 3996-4002, 2009 | 55 | 2009 |
| Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections E Ostorhazi, F Rozgonyi, A Sztodola, F Harmos, I Kovalszky, D Szabo, ... Journal of antimicrobial chemotherapy 65 (11), 2416-2422, 2010 | 53 | 2010 |
| Diazo transfer− click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation … G Pintér, G Batta, S Kéki, A Mándi, I Komáromi, K Takács-Novák, ... Journal of medicinal chemistry 52 (19), 6053-6061, 2009 | 51 | 2009 |
| Therapeutic utility of antibacterial peptides in wound healing L Otvos Jr, E Ostorhazi Expert review of anti-infective therapy 13 (7), 871-881, 2015 | 48 | 2015 |
| Reduced inflammatory threshold indicates skin barrier defect in transglutaminase 3 knockout mice P Bognar, I Nemeth, B Mayer, D Haluszka, N Wikonkal, E Ostorhazi, ... Journal of Investigative Dermatology 134 (1), 105-111, 2014 | 48 | 2014 |
| Eosinophilic fasciitis associated with Mycoplasma arginini infection P Silló, D Pintér, E Ostorházi, M Mazán, N Wikonkál, K Pónyai, ... Journal of clinical microbiology 50 (3), 1113-1117, 2012 | 46 | 2012 |
| Incidence and antibiotic susceptibility of genital mycoplasmas in sexually active individuals in Hungary K Pónyai, N Mihalik, E Ostorházi, B Farkas, L Párducz, M Marschalkó, ... European journal of clinical microbiology & infectious diseases 32, 1423-1426, 2013 | 44 | 2013 |
| Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo L Otvos Jr, E Ostorhazi, D Szabo, SD Zumbrun, LL Miller, SA Halasohoris, ... Frontiers in chemistry 6, 309, 2018 | 43 | 2018 |
| In vivo activity of optimized apidaecin and oncocin peptides against a multiresistant, KPC-producing Klebsiella pneumoniae strain E Ostorhazi, E Nemes-Nikodem, D Knappe, R Hoffmann Protein and Peptide Letters 21 (4), 368-373, 2014 | 38 | 2014 |
| Pharmacokinetics and in vivo efficacy of optimized oncocin derivatives R Schmidt, E Ostorházi, E Wende, D Knappe, R Hoffmann Journal of Antimicrobial Chemotherapy 71 (4), 1003-1011, 2016 | 35 | 2016 |
| Rapid systemic and local treatments with the antibacterial peptide dimer A3-APO and its monomeric metabolite eliminate bacteria and reduce inflammation in intradermal lesions … E Ostorhazi, E Voros, E Nemes-Nikodem, D Pinter, P Sillo, B Mayer, ... International journal of antimicrobial agents 42 (6), 537-543, 2013 | 34 | 2013 |
| In vivo Efficacy and Pharmacokinetics of Optimized Apidaecin Analogs R Schmidt, D Knappe, E Wende, E Ostorházi, R Hoffmann Frontiers in Chemistry 5, 15, 2017 | 32 | 2017 |
| Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: Synthesis and antiviral studies I Bereczki, M Kicsák, L Dobray, A Borbás, G Batta, S Kéki, ÉN Nikodém, ... Bioorganic & Medicinal Chemistry Letters 24 (15), 3251-3254, 2014 | 31 | 2014 |
| Intramuscularly administered peptide A3‐APO is effective against carbapenem‐resistant Acinetobacter baumannii in mouse models of systemic infections E Ostorhazi, F Rozgonyi, D Szabo, A Binas, M Cassone, JD Wade, ... Peptide Science 96 (2), 126-129, 2011 | 31 | 2011 |
